COSOPT - 0006-3629-60 - (DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE)

Alphabetical Index


Drug Information of COSOPT

Product NDC: 0006-3629
Proprietary Name: COSOPT
Non Proprietary Name: DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE
Active Ingredient(s): 20; 5    mg/mL; mg/mL & nbsp;   DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE
Administration Route(s): OPHTHALMIC
Dosage Form(s): SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of COSOPT

Product NDC: 0006-3629
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202667
Marketing Category: NDA
Start Marketing Date: 20120201

Package Information of COSOPT

Package NDC: 0006-3629-60
Package Description: 4 POUCH in 1 CARTON (0006-3629-60) > 15 AMPULE in 1 POUCH (0006-3629-15) > .2 mL in 1 AMPULE

NDC Information of COSOPT

NDC Code 0006-3629-60
Proprietary Name COSOPT
Package Description 4 POUCH in 1 CARTON (0006-3629-60) > 15 AMPULE in 1 POUCH (0006-3629-15) > .2 mL in 1 AMPULE
Product NDC 0006-3629
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE
Dosage Form Name SOLUTION
Route Name OPHTHALMIC
Start Marketing Date 20120201
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
Strength Number 20; 5
Strength Unit mg/mL; mg/mL
Pharmaceutical Classes Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]

Complete Information of COSOPT


General Information